What does elutia (cormatrix) — gross carrying value mean?

This represents the total initial value of royalty-based financial assets associated with the Elutia and CorMatrix product lines before any valuation adjustments. It serves as a baseline measure of the company's investment or acquired rights in these specific medical technologies. Monitoring this value helps investors understand the scale of the underlying asset base prior to accounting for impairments or allowances.

Ligand Pharmaceuticals LGND Elutia (CorMatrix) — Gross carrying value

Other product segments

Qarziba

$103.72M—

Similar metrics at other companies

WFCCumulative Gross Unrealized Gains

$145M+48.0%

MIRCumulative Gross Losses and Impairments

$211.8M0.0%

EBCCumulative Gross Losses and Impairments

$33.43M-16.4%

CECorporate and Other — Carrying Value

$5M0.0%

GHC

GHCCumulative Gross Losses and Impairments

$446.34M-24.0%

WMBGross Carrying Amount

$10.51B0.0%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.51B+96.7%

Enterprise value$5.4B+95.4%

P/E35.9×—

P/S20.1×+4.6×

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsGross.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's elutia (cormatrix) — gross carrying value.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's elutia (cormatrix) — gross carrying value?: Ligand Pharmaceuticals (LGND) reported elutia (cormatrix) — gross carrying value of $6.91M in Q1 2026.
What does elutia (cormatrix) — gross carrying value mean?: This represents the total initial value of royalty-based financial assets associated with the Elutia and CorMatrix product lines before any valuation adjustments. It serves as a baseline measure of the company's investment or acquired rights in these specific medical technologies. Monitoring this value helps investors understand the scale of the underlying asset base prior to accounting for impairments or allowances.